Medeon Biodesign, Inc. (TPEX:6499)
60.60
-4.40 (-6.77%)
Nov 20, 2026, 1:30 PM CST
Medeon Biodesign Revenue
Medeon Biodesign had revenue of 312.02M TWD in the quarter ending September 30, 2026, with 238.06% growth. This brings the company's total for the last twelve months to 647.79M, up 69.62% year-over-year. In the year 2025, Medeon Biodesign had annual revenue of 419.43M with 43.24% growth. That makes Medeon Biodesign the 34,026th largest company in the world by revenue and 1,775th in Taiwan.
Revenue (ttm)
647.79M
Revenue Growth
+69.62%
P/S Ratio
9.07
Revenue / Employee
16.61M
Employees
39
Market Cap
5.87B
Revenue by Segment
- Medical Parts Sales Department 253.47M 86.6%
- Development Department 39.34M 13.4%
Fiscal year ended Dec 31, 2024 See the full Medeon Biodesign breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 419.43M | 126.62M | 43.24% |
| Dec 31, 2024 | 292.81M | 96.55M | 49.19% |
| Dec 31, 2023 | 196.26M | -102.05M | -34.21% |
| Dec 31, 2022 | 298.32M | 229.36M | 332.61% |
| Dec 31, 2021 | 68.96M | -54.10M | -43.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Visco Vision | 5.02B |
| Formosa Optical Technology | 4.46B |
| Vizionfocus | 4.32B |
| St.Shine Optical | 3.63B |
| Pacific Hospital Supply | 2.43B |
| Bioteque | 2.28B |
| Nang Kuang Pharmaceutical | 2.09B |
| Bionime | 1.73B |